Manufacturers Trader Service OEM

Medical Predictive Science Corporation

2246 Ivy Road, Suite 17, 22903 Charlottesville, VA

Telephone +1 434 220-0715
Fax +1 240 220-6098

This company is co-exhibitor of
U.S. Department of Commerce, U.S. Commercial Service


Hall map

MEDICA 2016 hall map (Hall 16): stand C04

Fairground map

MEDICA 2016 fairground map: Hall 16

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.04  Intense medicine / anesthesiology / respiration
  • 01.04.04  Patient monitoring systems / Measuring stations

Patient monitoring systems / Measuring stations

Our products

Product category: Patient monitoring systems / Measuring stations

HeRO Symphony: MPSC’s premier product has a new name

Now called HeRO Symphony, MPSC continues to improve upon the capabilities of our foremost HeRO System with new advancements and capabilities. Supporting HL7 data export for sending HeRO Scores directly to your electronic medical record, new data acquisition methods for easier setup, and improved monitor connection cables, HeRO Symphony represents the highest level of capability that HeRO offers.
Now deployed on over 1,800 NICU beds in 14 countries!
HeRO has been proven to reduce infant mortality in the largest neonatal medical device clinical trial completed to date!
HeRO Symphony feature summary:

  • Supports patient transfer with data continuity.
  • Provides HeRO surveillance for all the beds in your NICU
  • Supports HeRO central viewing stations to view HeRO data
  • User access through a browser based client, works with tablets.
  • Provides an HL7 data stream to export to your electronic medical records
  • Archives HeRO Scores for up to one year.
  • Validated up to 256 bed NICU with 1 HeRO Server
  • HeRO Symphony can seamlessly integrate with HeRO ES to gain the advantages of a bedside view of HeRO plus all of the central monitoring functionality.

More Less

About us

Company details

Trends, hard limits, and alarms have been used for years to signal that a patient is currently deteriorating. HeRO is different. HeRO identifies subtle irregularities in heart rate variability that occur hours and days prior to patient deterioration and provides an early warning of patient distress. And unlike any other monitoring technology available, HeRO has been proven in the most rigorous scientific fashion to improve survival 1.

Released very early in infection, cytokines are the mediators of the inflammatory response. They have effects throughout the body, including the way the pacemaker of the heart responds to the autonomic nervous system. During the early stage of infection and other inflammatory events, characteristic abnormal heart rate patterns occur that HeRO has been trained to identify, and HeRO renders a score every hour that is the risk of infection in the next 24 hours2.

There is a large body of literature demonstrating that delays in antibiotic administration can increase mortality and morbidity3,4,5,6. Researchers hypothesized that by improving the timing of the diagnosis, HeRO monitoring might improve outcomes for NICU patients. They conducted the largest ever randomized control trial in neonatology, where 3,003 very low birthweight babies were randomized to either receive standard of care, or standard of care plus HeRO.

For patients in the HeRO monitored group, there was at least an 18 hour average difference in the timing of the rise in HeRO score relative to the diagnosis. And if the antibiotics can be started that much earlier, the infection can be nipped in the bud—before it goes systemic, before organs start shutting down, before the really bad outcomes occur. The HeRO monitored group benefitted from a 22% reduction in mortality. And there was no increase in antibiotic usage for healthy babies7.

Trends and limits tell you what is happening. HeRO is an early warning system that tells you what is going to happen. HeRO…Because timing is critical.

More Less